X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

PLATELETS

期刊標題檢索 PLATELETS 最新評論: How long does the first trial take? (2022-06-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[PLATELETS]您好,您是該頁面的第 38340 位訪客。

期刊簡介
期刊名稱PLATELETS PLATELETS
LetPub Score
6.3
50 ratings
Rate

Reputation
7.5

Influence
5.1

Speed
7.0

期刊簡稱PLATELETS
ISSN0953-7104
E-ISSN1369-1635
h-index60
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.700.8160.769
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q132 / 137

自引率 (2023-2024)4.00%自引率趨勢
掲載範囲
Platelets is an international, peer-reviewed journal covering all aspects of platelet- and megakaryocyte-related research.

Platelets provides the opportunity for contributors and readers across scientific disciplines to engage with new information about blood platelets. The journal’s Methods section aims to improve standardization between laboratories and to help researchers replicate difficult methods.

Research areas include:

Platelet function
Biochemistry
Signal transduction
Pharmacology and therapeutics
Interaction with other cells in the blood vessel wall
The contribution of platelets and platelet-derived products to health and disease

The journal publishes original articles, fast-track articles, review articles, systematic reviews, methods papers, short communications, case reports, opinion articles, commentaries, gene of the issue, and letters to the editor.

Platelets operates a single-blind peer review policy. Authors can choose to publish gold open access in this journal.
官方網站http://informahealthcare.com/loi/plt
在線稿件提交http://mc.manuscriptcentral.com/cpla
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區SCOTLAND
發行頻率隔月刊行
創刊年1990
每年文章數80每年文章數趨勢
黃金OA百分比45.69%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ3148/205
HEMATOLOGYSCIEQ241/97
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0953-7104%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【PLATELETS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS MOLECULAR CELL BIOLOGYH-index: 386

    CiteScore: 173.60
    CELL RESEARCHH-index: 143

    CiteScore: 53.90
    Cell Stem CellH-index: 212

    CiteScore: 37.10
    NATURE CELL BIOLOGYH-index: 337

    CiteScore: 28.40
    AutophagyH-index: 121

    CiteScore: 21.30
    TRENDS IN CELL BIOLOGYH-index: 215

    CiteScore: 32.00
    JOURNAL OF CELL BIOLOGYH-index: 353

    CiteScore: 12.60
    CURRENT OPINION IN CELL BIOLOGYH-index: 242

    CiteScore: 14.60
    CELL PROLIFERATIONH-index: 66

    CiteScore: 14.80
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYH-index: 142

    CiteScore: 10.70
    學科內最受檢索的期刊 頁面查看次數
    Oxidative Medicine and Cellular Longevity248148
    CELL RESEARCH237698
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE184513
    BIOSCIENCE REPORTS157789
    Autophagy154655
    EXPERIMENTAL CELL RESEARCH134892
    CELL PROLIFERATION134494
    NATURE CELL BIOLOGY127696
    MOLECULAR AND CELLULAR BIOCHEMISTRY115713
    PLANT AND CELL PHYSIOLOGY114823
  •  

    PLATELETS PLATELETS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [PLATELETS] 的評論撰寫評論
作者: 东风璠瑜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-20 16:32:17 評論於
How long does the first trial take?
(0) 讚! | 东风璠瑜

作者: 东风璠瑜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-17 09:21:47 評論於
The official website of the magazine cannot be submitted???
(0) 讚! | 东风璠瑜

作者: 终幕以寒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-22 13:07:34 評論於
Have you won?
(0) 讚! | 终幕以寒

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:02:59 評論於
Relationship between the research findings and relevant theories; Limitations or shortcomings of your study; Practical significance and application value of the research in real situations; Suggestions for future research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:17:33 評論於
We suggest dividing the discussion of research limitations into three parts: (1) identify research limitations; (2) explain research limitations in detail; and (3) propose future research directions or improvement solutions. Discussing research limitations in this order can help you clearly identify research shortcomings without compromising the quality and validity of the study
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:13:30 評論於
What can usually be discussed in discussions?
(0) 讚! | Darlene Pepys

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-25 15:31:11 評論於
How to write about limitations in a discussion?
(0) 讚! | 北国博达

作者: 淑雅mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-12-21 09:23:07 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Experience sharing: First submitted a letter, waited for almost three months and was directly accepted; then submitted an article on a platelet-related indicator in infectious diseases research, which is not very related to blood overall, and was rejected on the same day, without delaying further submissions. Feeling the speed is slightly slow, currently waiting for proof of the letter, open access is optional. Overall, very fortunate, even though it's a letter, after all, it's my first English article
(0) 讚! | 淑雅mio

作者: Alma Bunyan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-11-13 23:28:56 評論於
The article submitted on November 4th was displayed in the review two days later, and it has been in review status all along. Is the review cycle fast? I am in a hurry to graduate and need the article. Please advise
(0) 讚! | Alma Bunyan

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-01 09:21:42 評論於
Submitted in mid-March, still under review
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-12-22 20:27:48 評論於
Review speed: 12.0 | Submission hit rate: 75.0
Experience sharing: The journal where our lab's master's degree students are guaranteed to be published... Generally, submitting data on the sidelines can lead to acceptance
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-10-15 13:26:17 評論於
This magazine supports open access, so there will be charges. If it is not open access, there will be no page fees
(0) 讚! | 凌霄高洁

作者: 宗室浩涆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-31 09:05:48 評論於
Do you charge a layout fee?
(0) 讚! | 宗室浩涆

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-26 14:32:44 評論於
The review speed is very fast, around 20 days
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-07-01 19:38:01 評論於
Crossed over 2 points, will it be slightly better next year, very hopeful
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-06-15 18:40:21 評論於
Today I submitted a paper on the relationship between platelets and cardiovascular diseases, waiting for the results!
(0) 讚! | 凌霄高洁

作者: 明冠以莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-07-11 15:09:50 評論於
I have published an article in the Platelets journal, and one year later I was invited to be a reviewer for the journal. The journal has a very quick review process, with reviewers' comments typically returned within 10-14 days
(0) 讚! | 明冠以莲

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2012-07-11 12:55:00 評論於
I published an article in Platelets journal and was invited to be a reviewer for the journal a year later. The journal reviews the papers very quickly and generally returns the reviewers' opinions in about 10-14 days.

(0) 讚! | 匿名

作者: 福特布莱克


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-10-25 16:01:25 評論於
Overall, it's very good, and the review speed is also relatively fast, about 4 weeks
(0) 讚! | 福特布莱克

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [PLATELETS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*